Searched for
MRNA BUSINESS
Emcure buys remaining 12.05% in Gennova to take full controlEmcure Pharma is acquiring the remaining stake in Gennova Biopharmaceuticals. This move simplifies ownership and sharpens strategic focus f...- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Watching his dog slowly die, techie refused to give up. Then he used AI and created a custom 'cancer vaccine' for his pet friendAustralian tech expert Paul Conyngham used artificial intelligence to help save his dog Rosie, a Staffy-Shar Pei mix, after she was diagnos...
- FDA issues new heart risk warnings for Pfizer, Moderna COVID vaccines - should you be worried?The FDA has issued warnings regarding potential cardiac risks, specifically myocarditis and pericarditis, associated with the Pfizer and Mo...
- Novavax soars 146% on $1.2 billion Sanofi vaccine licensing dealThe pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Sanofi says it's back to the drawing board on mRNA flu vaccinesSanofi, one of the top global vaccine makers, has stated that the current mRNA technology used in COVID-19 vaccines is not effective agains...
- India may not change its Covid vaccination plan: Official"We are doing well with the present strategy and hence there is no need to make changes in the vaccination programme, which is already work...
- AstraZeneca may not stay in vaccines, but CEO has no COVID regretsSoriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures ...
- Covishield offers longer immunity than mRNA jabs, says Adar PoonawallaPoonawalla, ET's Business Leader Of the Year for 2021, was optimistic that final approvals for administering Covovax to children would come...
- Texas Lone Rangers vs Covid-19No praise is enough for Peter Hotez and Maria Elena Bottazzi, the Texans who might yet rescue the world. They have done what big government...
- Here’s why developing countries can make COVID-19 mRNA vaccinesDepending on wealthy nations to donate billions of doses is not working, public health experts say. The solution, many now believe, is for ...
- EU to purchase 100 million more vaccine dosesThe announcement offers a much-needed boost to the EU's sluggish and much-criticised vaccine rollout. Sean Marett, the chief business offic...
- India may have 500 million Covid-19 vaccine doses by MarchCompanies such as Zydus Cadila, Bharat Biotech, Dr Reddys-Gamaleya Institute, Serum Institute-AstraZeneca and Gennova are expected to submi...
- View: Why are all the prominent Covid vaccines developed by women?In business, academia and other fields of science, women do not have roles nearly as prominent as they do right now in vaccine development....
- The understated husband-and-wife 'dream team' behind Pfizer's coronavirus vaccinePfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The compan...
- Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large s...
- Wipro founder Azim Premji is an early investor in US firm ModernaWipro founder Azim Premji is an investor in Moderna, the firm that has emerged a frontrunner for Covid vaccine.
- US begins first human trial of coronavirus vaccine: OfficialsThe vaccine is called mRNA-1273 and was developed by the NIAID scientists and their collaborators at the biotechnology company Moderna, Inc...
Load More
